Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Clinical and molecular characterization of Brazilian familie4s with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation (2010)

  • Authors:
  • USP affiliated authors: MOLFETTA, GREICE ANDREOTTI DE - FMRP ; SILVA JUNIOR, WILSON ARAÚJO DA - FMRP
  • USP Schools: FMRP; FMRP
  • DOI: 10.1007/s10689-010-9357-2
  • Subjects: NEOPLASIAS; MUTAÇÃO GENÉTICA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10689-010-9357-2 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Familial Cancer

    ISSN: 1389-9600

    Citescore - 2017: 2.03

    SJR - 2017: 0.963

    SNIP - 2017: 0.722


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2150923pcd 2150923 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GOMY, Israel; MOLFETTA, Greice Andreotti de; BARRETO, Ester de Andrade; et al. Clinical and molecular characterization of Brazilian familie4s with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation. Familial Cancer, Dordrecht, v. 0, n. 4, p. 635-642, 2010. DOI: 10.1007/s10689-010-9357-2.
    • APA

      Gomy, I., Molfetta, G. A. de, Barreto, E. de A., Ferreira, C. A., Zanette, D. L., Rocha, J. C. C. da, & Silva Júnior, W. A. da. (2010). Clinical and molecular characterization of Brazilian familie4s with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation. Familial Cancer, 0( 4), 635-642. doi:10.1007/s10689-010-9357-2
    • NLM

      Gomy I, Molfetta GA de, Barreto E de A, Ferreira CA, Zanette DL, Rocha JCC da, Silva Júnior WA da. Clinical and molecular characterization of Brazilian familie4s with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation. Familial Cancer. 2010 ; 0( 4): 635-642.
    • Vancouver

      Gomy I, Molfetta GA de, Barreto E de A, Ferreira CA, Zanette DL, Rocha JCC da, Silva Júnior WA da. Clinical and molecular characterization of Brazilian familie4s with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation. Familial Cancer. 2010 ; 0( 4): 635-642.

    Referências citadas na obra
    Maher ER, Kaelin WG (1997) von Hippel-Lindau disease. Medicine (Baltimore) 76:381–391
    Maher ER, Iselius L, Yates JR et al (1991) von Hippel-Lindau disease: a genetic study. J Med Genet 28:443–447
    Knudson AGL (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823
    Richards FM, Crossey PA, Phipps ME et al (1994) Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum Mol Genet 3:595–598
    Gnarra JR, Tory K, Weng Y et al (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85–90
    Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275
    Crossey PA, Richards FM, Foster K et al (1994) Identification of intragenic mutations in the von Hippel-Lindau tumor suppressor gene and correlations with disease phenotype. Hum Mol Genet 3:1303–1308
    Maher ER, Webster AR, Richards FM et al (1996) Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 33:328–332
    Stolle C, Glenn G, Zbar B et al (1998) Improved detection of germline mutations in the von Hippel-Lindau tumor suppressor gene. Hum Mutat 12:417–423
    Hoebeeck J, van der Luijt RB, Poppe B et al (2005) Rapid detection of VHL exon deletions using real-time quantitative PCR. Lab Invest 85:24–33
    Hattori K, Teranishi J, Stolle C et al (2006) Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease. Cancer Sci 97:400–405
    Hes FJ, van der Luijt RB, Janssen ALW et al (2007) Frequency of von Hippel-Lindau germline mutations in classic and non-classic von Hippel-Lindau disease identified by DNA sequenciang Southern blot analysis and multiplex ligation-dependent probe amplification. Clin Genet 72:122–129
    Chen F, Kishida T, Yao M et al (1995) Germline mutations in von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66–75
    Zbar B, Kishida T, Chen F et al (1996) Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe and Japan. Hum Mutat 8:348–357
    Mc Neill A, Rattenberry E, Barber R et al (2009) Genotype-phenotype correlations in VHL exon deletions. Am J Med Genet Part A 149A:2147–2151
    Cascón A, Escobar B, Montero-Conde C et al (2007) Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients. Hum Mutat 28:613–621
    Franke G, Bausch B, Hoffmann M et al (2009) Alu-Alu recombination underlies the vast majority of large VHL germline deletions: molecular characterization and genotype-phenotype correlations in VHL patients. Hum Mutat 30:776–786
    Ong KR, Woodward ER, Killick P et al (2007) Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat 28:143–149
    Rocha JC, Silva RL, Mendonça BB et al (2003) High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil. J Med Genet 40:e31
    American Society of Clinical Oncology (2003) Policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21:1–10
    Gallou C, Chauveau D, Richard S et al (2004) Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat 24:215–224
    Oberstrass J, Reifenberger G, Reifenberger J et al (1996) Mutation of the von Hippel-Lindau tumour suppressor gene in capillary hemangioblastomas of the central nervous system. J Pathol 179:151–156
    Olschwang S, Richard S, Boisson C et al (1998) Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Hum Mutat 12:424–430
    Berkeley Drosophila Genome Project (BDGP) Splice site prediction by neural network. http://www.fruitfly.org/seq_tools/splice.html . Cited 4 July 2009
    The Human Gene Mutation Database (HGMD). http://www.uwcmml1s.uwcm.ac.uk/uwcm/mg/search/120488.html . Cited 4 July 2009
    The Universal Mutation Database. http://www.umd.be . Cited 4 July 2009
    Human Genome Variation Society Database (HGVS). http://www.ncbi.nlm.nih.gov/SNP/tranSNP/tranSNP.cgi . Cited 4 July 2009
    Hes FJ, McKee S, Taphoorn MJ et al (2000) Cryptic von Hippel-Lindau disease: germline mutations in patients with hemangioblastoma only. J Med Genet 37:939–943